Additional Information
Book Details
Abstract
Essence of Anesthesiology Practice makes it easy to formulate anesthesia plans through a consistent format and discussions of the problems, causes, comorbidities, and anesthesia implications for over 600 clinical topics. Drs. Fleisher and Roizen present a completely revised new edition that includes coverage of many new conditions, procedures, and drugs.
- Easily formulate anesthesia plans through a consistent format that covers a single clinical topic on each page, with a review of its problems, causes, comorbidities, and anesthesia implications.
- Get state-of-art, reliable coverage from an international team of experts who discuss common and rare conditions and how to manage them.
- Understand the interactions of common drugs and alternative medicine so that you can develop anesthesia plans accordingly.
- Quickly reference key information using the carefully templated text that highlights the most important anesthetic considerations in a consistent, user-friendly layout.
- Stay current on the latest anesthetic implications in regards to coexisting diseases, procedures, drugs, and alternative and complementary therapies, including coverage of mitochondrial myopathy, atrial fibrillation ablation, awake craniotomy, stereotactic neurosurgery, neuroprotection, dexmedetomidine, and other hot topics.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Essence of Anesthesia Practice | iii | ||
| Copyright | iv | ||
| Dedication | v | ||
| Contributors | vii | ||
| Foreword | xxxiii | ||
| Preface | xxxv | ||
| Contents | xxxvii | ||
| Abbreviations | xliii | ||
| Symbols | xliii | ||
| Section I: Diseases | 1 | ||
| Abruptio Placentae | 2 | ||
| Assessment Points | 2 | ||
| Achondroplasia, Dwarfism | 3 | ||
| Assessment Points | 3 | ||
| Acidosis, Lactic/Metabolic | 5 | ||
| Assessment Points | 5 | ||
| Acromegaly | 6 | ||
| Assessment Points | 6 | ||
| Acute Respiratory Distress Syndrome (ARDS) | 8 | ||
| Assessment Points | 8 | ||
| Addison’s Disease | 9 | ||
| Assessment Points | 9 | ||
| Adrenal Insufficiency, Acute or Secondary | 10 | ||
| Assessment Points | 10 | ||
| Alcohol Abuse | 11 | ||
| Assessment Points | 11 | ||
| Allergy | 12 | ||
| Assessment Points | 12 | ||
| Amniotic Fluid Embolism | 13 | ||
| Assessment Points | 13 | ||
| Anaphylaxis | 16 | ||
| Assessment Points | 16 | ||
| Anemia, Aplastic | 17 | ||
| Assessment Points | 17 | ||
| Anemia, Chronic Disease/Inflammation | 18 | ||
| Assessment Points | 18 | ||
| Anemia, Hemolytic | 19 | ||
| Assessment Points | 19 | ||
| Angina, Chronic Stable | 20 | ||
| Assessment Points | 20 | ||
| Anhidrosis (Congenital Anhidrotic Ectodermanl Dysplasia) | 21 | ||
| Assessment Points | 21 | ||
| Ankylosing Spondylitis | 22 | ||
| Assessment Points | 22 | ||
| Anomalous Pulmonary Venous Drainage | 23 | ||
| Assessment Points | 23 | ||
| Anorexia Nervosa | 24 | ||
| Assessment Points | 24 | ||
| Anticoagulation, Preoperative | 26 | ||
| Assessment Points | 26 | ||
| Antithrombin III Deficiency | 27 | ||
| Assessment Points | 27 | ||
| Aortic Regurgitation | 28 | ||
| Assessment Points | 28 | ||
| Aortic Stenosis | 29 | ||
| Assessment Points | 29 | ||
| Apnea of the Newborn | 30 | ||
| Assessment Points | 30 | ||
| Appendicitis, Acute | 31 | ||
| Assessment Points | 31 | ||
| Aspiration, Perioperative: Prevention and Management | 32 | ||
| Assessment Points | 32 | ||
| Asthma, Acute | 33 | ||
| Assessment Points | 33 | ||
| Atherosclerotic Disease | 34 | ||
| Assessment Points | 34 | ||
| Atrial Fibrillation | 35 | ||
| Assessment Points | 35 | ||
| Atrial Flutter | 36 | ||
| Assessment Points | 36 | ||
| Atrial Septal Defect, Ostium Primum | 37 | ||
| Assessment Points | 37 | ||
| Atrial Septal Defect, Ostium Secundum | 38 | ||
| Assessment Points | 38 | ||
| Autoimmune Diseases, Cold | 39 | ||
| Assessment Points | 39 | ||
| Autonomic Dysreflexia (AD) | 40 | ||
| Assessment Points | 40 | ||
| AV and Bifascicular Heart Block | 41 | ||
| Assessment Points | 41 | ||
| Beckwith-Wiedemann Syndrome | 42 | ||
| Assessment Points | 42 | ||
| Bilirubinemia of the Newborn | 43 | ||
| Assessment Points | 43 | ||
| Blebs and Bullae | 44 | ||
| Assessment Points | 44 | ||
| Bleomycin Sulfate Toxicity | 45 | ||
| Assessment Points | 45 | ||
| Blindness | 46 | ||
| Assessment Points | 46 | ||
| Botulism | 47 | ||
| Assessment Points | 47 | ||
| Brain Death | 49 | ||
| Assessment Points | 49 | ||
| Bronchiectasis | 50 | ||
| Assessment Points | 50 | ||
| Bronchiolitis Obliterans Syndrome | 51 | ||
| Assessment Points | 51 | ||
| Bronchitis, Chronic | 53 | ||
| Assessment Points | 53 | ||
| Bronchiopulmonary Dysplasia | 54 | ||
| Assessment Points | 54 | ||
| Buerger’s Disease: Thromboangiitis Obliterans | 55 | ||
| Assessment Points | 55 | ||
| Bulimia | 56 | ||
| Assessment Points | 56 | ||
| Burn Injury, Chemical | 57 | ||
| Assessment Points | 57 | ||
| Burn Injury, Electrical | 58 | ||
| Assessment Points | 58 | ||
| Burn Injury, Flame | 60 | ||
| Assessment Points | 60 | ||
| Calcium Deficiency/Hypocalcemia | 61 | ||
| Assessment Points | 61 | ||
| Cancer, Bladder | 62 | ||
| Assessment Points | 62 | ||
| Cancer, Breast | 63 | ||
| Assessment Points | 63 | ||
| Cancer, Bronchial | 64 | ||
| Assessment Points | 64 | ||
| Cancer, Esophageal | 65 | ||
| Assessment Points | 65 | ||
| Cancer, Lung Parenchyma | 66 | ||
| Assessment Points | 66 | ||
| Cancer, Prostate | 67 | ||
| Assessment Points | 67 | ||
| Candidiasis | 68 | ||
| Assessment Points | 68 | ||
| Carbon Monoxide (CO) Poisoning | 69 | ||
| Assessment Points | 69 | ||
| Carcinoid Syndrome | 70 | ||
| Assessment Points | 70 | ||
| Cardiomyopathy, Alcoholic | 71 | ||
| Assessment Points | 71 | ||
| Cardiomyopathy, Hypertrophic (HCM) | 72 | ||
| Assessment Points | 72 | ||
| Cardiomyopathy, Ischemic | 74 | ||
| Assessment Points | 74 | ||
| Carnitine Deficiency | 75 | ||
| Assessment Points | 75 | ||
| Carotid Sinus Syndrome | 76 | ||
| Assessment Points | 76 | ||
| Central Neurogenic Hyperventilation | 77 | ||
| Assessment Points | 77 | ||
| Cephalopelvic Disproportion | 78 | ||
| Assessment Points | 78 | ||
| Cerebral Arteriovenous \nMalformations (AVMs) | 79 | ||
| Assessment Points | 79 | ||
| Cerebral Palsy | 80 | ||
| Assessment Points | 80 | ||
| Cerebrovascular Transient Ischemic Attack (TIA) | 81 | ||
| Assessment Points | 81 | ||
| Cervical Disk Disease (Cervical Spine Disease) | 82 | ||
| Assessment Points | 82 | ||
| Chagas’ Disease | 83 | ||
| Assessment Points | 83 | ||
| Cherubism | 84 | ||
| Assessment Points | 84 | ||
| Cigarette Smoking | 85 | ||
| Assessment Points | 85 | ||
| Cigarette Smoking Cessation | 86 | ||
| Assessment Points | 86 | ||
| Cleft Palate | 87 | ||
| Assessment Points | 87 | ||
| Coagulopathy, Factor IX Deficiency | 88 | ||
| Assessment Points | 88 | ||
| Coarctation of the Aorta | 89 | ||
| Assessment Points | 89 | ||
| Complement Deficiency | 90 | ||
| Assessment Points | 90 | ||
| Congenital Pulmonary Cystic Lesions/Lobar Emphysema | 91 | ||
| Assessment Points | 91 | ||
| Congenital Methemoglobinemia | 92 | ||
| Assessment Points | 92 | ||
| Congestive Heart Failure | 93 | ||
| Assessment Points | 93 | ||
| Conn’s Syndrome | 95 | ||
| Assessment Points | 95 | ||
| Constipation | 96 | ||
| Assessment Points | 96 | ||
| Conversion Disorder | 97 | ||
| Assessment Points | 97 | ||
| Cor Pulmonale | 98 | ||
| Assessment Points | 98 | ||
| Coronary Artery Disease (Left Main and Non-Left Main Disease) | 99 | ||
| Assessment Points | 99 | ||
| Coronary Artery Spasm (CAS) | 101 | ||
| Assessment Points | 101 | ||
| Craniosynostosis | 102 | ||
| Assessment Points | 102 | ||
| CREST Syndrome | 103 | ||
| Assessment Points | 103 | ||
| Cri Du Chat Syndrome \n(5p Syndrome) | 104 | ||
| Assessment Points | 104 | ||
| Crohn’s Disease | 105 | ||
| Assessment Points | 105 | ||
| Croup (Laryngotracheobronchitis) | 106 | ||
| Assessment Points | 106 | ||
| Cryptococcus Infection | 107 | ||
| Assessment Points | 107 | ||
| Cushing’s Syndrome | 108 | ||
| Assessment Points | 108 | ||
| Cyanide Poisoning | 109 | ||
| Assessment Points | 109 | ||
| Cystic Fibrosis | 110 | ||
| Assessment Points | 110 | ||
| Cytomegalovirus Infection | 111 | ||
| Assessment Points | 111 | ||
| Deep Vein Thrombosis | 112 | ||
| Assessment Points | 112 | ||
| Degenerative Disk Disease | 113 | ||
| Assessment Points | 113 | ||
| Delirium (Postanesthetic) | 114 | ||
| Assessment Points | 114 | ||
| Dementia | 115 | ||
| Assessment Points | 115 | ||
| Depression, Unipolar | 117 | ||
| Assessment Points | 117 | ||
| Diabetes, Type I (Insulin-Dependent) | 118 | ||
| Assessment Points | 118 | ||
| Diabetes, Type II (Noninsulin-Dependent) | 119 | ||
| Assessment Points | 119 | ||
| Diabetes, Type III (Gestational Diabetes Mellitus) | 120 | ||
| Assessment Points | 120 | ||
| Diabetes Insipidus | 121 | ||
| Assessment Points | 121 | ||
| Diabetic Ketoacidosis (DKA) | 122 | ||
| Assessment Points | 122 | ||
| Diaphragmatic Hernia (Congenital) | 123 | ||
| Assessment Points | 123 | ||
| Diarrhea, Acute and Chronic | 124 | ||
| Assessment Points | 124 | ||
| Dilated Cardiomyopathy (DCM) | 125 | ||
| Assessment Points | 125 | ||
| Diphtheria | 126 | ||
| Assessment Points | 126 | ||
| Disseminated Intravascular Coagulation (DIC) | 128 | ||
| Assessment Points | 128 | ||
| Diverticulosis | 129 | ||
| Assessment Points | 129 | ||
| Do Not Resuscitate (DNR) Orders | 130 | ||
| Assessment Points | 130 | ||
| Double Aortic Arch | 131 | ||
| Assessment Points | 131 | ||
| Down Syndrome | 133 | ||
| Assessment Points | 133 | ||
| Drug Abuse, Lysergic Acid Diethylamide (LSD) | 134 | ||
| Assessment Points | 134 | ||
| Drug Overdose, Rat Poison (Warfarin Toxicity) | 135 | ||
| Assessment Points | 135 | ||
| Duchenne Muscular Dystrophy (Pseudohypertrophic Muscular Dystrophy) | 136 | ||
| Assessment Points | 136 | ||
| Duodenal Atresia | 137 | ||
| Assessment Points | 137 | ||
| Echinococcosis | 138 | ||
| Assessment Points | 138 | ||
| Eclampsia | 140 | ||
| Assessment Points | 140 | ||
| Eisenmenger’s Syndrome | 141 | ||
| Assessment Points | 141 | ||
| Emphysema | 143 | ||
| Assessment Points | 143 | ||
| Encephalitis | 144 | ||
| Assessment Points | 144 | ||
| Encephalopathy, Hypertensive | 145 | ||
| Assessment Points | 145 | ||
| Encephalopathy, Metabolic | 147 | ||
| Assessment Points | 147 | ||
| Encephalopathy, Postanoxic | 148 | ||
| Assessment Points | 148 | ||
| Endocardial \nCushion Defect | 149 | ||
| Assessment Points | 149 | ||
| Epidermolysis Bullosa | 150 | ||
| Assessment Points | 150 | ||
| Epiglottitis | 151 | ||
| Assessment Points | 151 | ||
| Familial Dysautonomia \n(Riley-Day Syndrome) | 152 | ||
| Assessment Points | 152 | ||
| Familial Periodic Paralysis (Hyperkalemic) | 153 | ||
| Assessment Points | 153 | ||
| Familial Periodic Paralysis (Hypokalemic) | 154 | ||
| Assessment Points | 154 | ||
| Fat Embolism | 155 | ||
| Assessment Points | 155 | ||
| Foreign Body Aspiration | 156 | ||
| Assessment Points | 156 | ||
| Friedreich’s Ataxia | 157 | ||
| Assessment Points | 157 | ||
| Gastrinoma | 158 | ||
| Assessment Points | 158 | ||
| Gastroesophageal Reflux \nin Children | 159 | ||
| Assessment Points | 159 | ||
| Glaucoma, Closed-Angle | 160 | ||
| Assessment Points | 160 | ||
| Glaucoma, Open-Angle | 161 | ||
| Assessment Points | 161 | ||
| Glomus Jugulare Tumors | 162 | ||
| Assessment Points | 162 | ||
| Glossopharyngeal Neuralgia | 163 | ||
| Assessment Points | 163 | ||
| Gonorrhea | 164 | ||
| Assessment Points | 164 | ||
| Guillain-Barré Syndrome | 165 | ||
| Assessment Points | 165 | ||
| Hashimoto’s Thyroiditis | 166 | ||
| Assessment Points | 166 | ||
| Headache, Migraine | 167 | ||
| Assessment points (Mainly side effects and toxicity of antimigrainous therapy.) | 167 | ||
| HELLP Syndrome | 168 | ||
| Assessment Points | 168 | ||
| Hemophilia | 169 | ||
| Assessment Points | 169 | ||
| Hepatic Encephalopathy (HE) | 170 | ||
| Assessment Points | 170 | ||
| Hepatitis, Alcoholic | 171 | ||
| Assessment Points | 171 | ||
| Hepatitis, Halothane | 172 | ||
| Assessment Points | 172 | ||
| Hepatitis A | 173 | ||
| Assessment Points | 173 | ||
| Hepatitis B | 175 | ||
| Assessment Points | 175 | ||
| Hepatitis C | 176 | ||
| Assessment Points | 176 | ||
| Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Disease) | 178 | ||
| Assesment Points | 178 | ||
| Herniated Nucleus Pulposus | 179 | ||
| Assessment Points | 179 | ||
| Herpes, Type I | 180 | ||
| Assessment points | 180 | ||
| Herpes, Type II | 181 | ||
| Assessment Points (Primary and Recurrent) | 181 | ||
| Hirschsprung’s Disease | 182 | ||
| Assessment Points | 182 | ||
| Histiocytosis | 183 | ||
| Assessment Points | 183 | ||
| Hydrocephalus | 184 | ||
| Assessment Points | 184 | ||
| Hyperaldosteronism (Secondary) | 185 | ||
| Assessment Points | 185 | ||
| Hypercalcemia | 186 | ||
| Assessment Points | 186 | ||
| Hypercholesterolemia | 188 | ||
| Assessment Points | 188 | ||
| Hyperglycemia | 189 | ||
| Assessment Points | 189 | ||
| Hyperkalemia | 190 | ||
| Assessment Points | 190 | ||
| Hypermagnesemia | 191 | ||
| Assessment Points | 191 | ||
| Hypernatremia | 192 | ||
| Assessment Points | 192 | ||
| Hyperglycemic Hyperosmolar State (HHS) | 193 | ||
| Assessment Points | 193 | ||
| Hyperparathyroidism | 194 | ||
| Assessment Points | 194 | ||
| Hypertension | 195 | ||
| Assessment Points | 195 | ||
| Hypertension, Uncontrolled with Cardiomyopathy | 197 | ||
| Assessment Points | 197 | ||
| Hyperthyroidism | 198 | ||
| Assessment Points | 198 | ||
| Hypertriglyceridemia | 199 | ||
| Assessment Points | 199 | ||
| Hypokalemia | 200 | ||
| Assessment Points | 200 | ||
| Hypomagnesemia | 201 | ||
| Assessment Points | 201 | ||
| Hyponatremia | 203 | ||
| Assessment Points | 203 | ||
| Hypophosphatemia | 205 | ||
| Assessment Points | 205 | ||
| Hypopituitarism | 206 | ||
| Assessment Points | 206 | ||
| Hypothermia, Mild | 208 | ||
| Assessment Points | 208 | ||
| Hypothyroidism | 209 | ||
| Assessment Points | 209 | ||
| Hypoxemia | 210 | ||
| Assessment Points | 210 | ||
| IgA Deficiency | 211 | ||
| Assessment Points | 211 | ||
| Immune Suppression | 212 | ||
| Assessment Points | 212 | ||
| Implantable Cardioverter-Defibrillators (ICDs) | 213 | ||
| Assessment Points | 213 | ||
| Infratentorial Tumors | 215 | ||
| Assessment Points | 215 | ||
| Insulinoma | 216 | ||
| Assessment points | 216 | ||
| Intracranial Hypertension (ICH) | 217 | ||
| Assessment Points | 217 | ||
| Intraoperative Recall | 218 | ||
| Assessment Points | 218 | ||
| Jaundice | 219 | ||
| Assessment Points | 219 | ||
| Jehovah’s Witness Patient | 221 | ||
| Assessment Points | 221 | ||
| Jeune Syndrome (Asphyxiating Thoracic Dystrophy) | 222 | ||
| Assessment Points | 222 | ||
| Kartagener’s Syndrome | 223 | ||
| Assessment Points | 223 | ||
| Klippel-Feil Syndrome | 224 | ||
| Assessment Points | 224 | ||
| Latex Allergy | 225 | ||
| Assessment Points | 225 | ||
| Lesch-Nyhan Syndrome | 226 | ||
| Assessment Points | 226 | ||
| Leukemia | 227 | ||
| Assessment Points | 227 | ||
| Lipidemias | 228 | ||
| Assessment Points | 228 | ||
| Ludwig’s Angina | 229 | ||
| Assessment Points | 229 | ||
| Lyme Disease | 230 | ||
| Assessment Points | 230 | ||
| Lymphomas | 231 | ||
| Assessment Points | 231 | ||
| Malignant Hyperthermia (MH) and Other Anesthetic-Induced Myodystrophies (AIM) | 232 | ||
| Assessment Points | 232 | ||
| Malnutrition | 234 | ||
| Assessment Points | 234 | ||
| Marfan’s Syndrome | 235 | ||
| Assessment Points | 235 | ||
| Mastocytosis | 236 | ||
| Assessment Points | 236 | ||
| Mediastinal Masses | 238 | ||
| Assessment Points | 238 | ||
| Mesothelioma | 240 | ||
| Assessment Points | 240 | ||
| Methemoglobinemia | 241 | ||
| Assessment Points | 241 | ||
| Mitochondrial Myopathy | 242 | ||
| Assessment Points | 242 | ||
| Mitral Regurgitation | 243 | ||
| Assessment Points | 243 | ||
| Mitral Stenosis | 244 | ||
| Assessment Points | 244 | ||
| Mitral Valve Prolapse | 245 | ||
| Assessment Points | 245 | ||
| Mobitz I (Second-Degree Atrioventricular Block) | 246 | ||
| Assessment Points | 246 | ||
| Mobitz II (Second-Degree Atrioventricular Block) | 247 | ||
| Assessment Points | 247 | ||
| Morbid Obesity | 248 | ||
| Assessment Points | 248 | ||
| Moyamoya | 249 | ||
| Assessment Points | 249 | ||
| Mucopolysaccharidoses | 250 | ||
| Assessment Points | 250 | ||
| Multiple Endocrine Neoplasia (MEN) Type I and II | 252 | ||
| Assessment Points | 252 | ||
| Multiple Myeloma | 254 | ||
| Assessment Points | 254 | ||
| Multiple Sclerosis | 255 | ||
| Assessment Points | 255 | ||
| Multisystem Organ Failure, Lung Dysfunction In | 256 | ||
| Assessment Points | 256 | ||
| Myasthenia Gravis | 257 | ||
| Assessment Points | 257 | ||
| Mycoplasma pneumoniae Infection | 258 | ||
| Assessment Points | 258 | ||
| Myocardial Contusion (Blunt Cardiac Injury) | 259 | ||
| Assessment Points | 259 | ||
| Myocardial Ischemia (MIsch) | 260 | ||
| Assessment Points | 260 | ||
| Myotonia Dystrophica (Myotonic Dystrophy, Steinert’s Disease) | 261 | ||
| Assessment Points | 261 | ||
| Myxoma | 263 | ||
| Assessment Points | 263 | ||
| Narcolepsy | 264 | ||
| Assessment Points | 264 | ||
| Necrotizing Enterocolitis | 265 | ||
| Assessment Points | 265 | ||
| Necrotizing Fasciitis | 266 | ||
| Assessment Points | 266 | ||
| Neurofibromatosis (NF) | 268 | ||
| Assessment Points | 268 | ||
| Occlusive Cerebrovascular Disease | 269 | ||
| Assessment Points | 269 | ||
| Opitz-Frias Syndrome \n(The G Syndrome) | 270 | ||
| Assessment Points | 270 | ||
| Osteoarthritis | 271 | ||
| Assessment Points | 271 | ||
| Osteoporosis | 272 | ||
| Assessment Points | 272 | ||
| Otitis Media | 273 | ||
| Assessment Points | 273 | ||
| Pacemakers | 275 | ||
| Assessment Points | 275 | ||
| Pancreatitis, Acute | 277 | ||
| Assessment Points | 277 | ||
| Pancreatitis, Chronic | 278 | ||
| Assessment Points | 278 | ||
| Parkinson’s Disease (Paralysis Agitans) | 279 | ||
| Assessment Points | 279 | ||
| Paroxysmal Atrial Tachycardia | 281 | ||
| Assessment Points | 281 | ||
| Patent Ductus Arteriosus | 282 | ||
| Assessment Points | 282 | ||
| Pemphigus | 283 | ||
| Assessment Points | 283 | ||
| Pericardial Effusion | 284 | ||
| Assessment Points | 284 | ||
| Pericarditis, Constrictive | 285 | ||
| Assessment Points | 285 | ||
| Peripheral Vascular Disease | 286 | ||
| Assessment Points | 286 | ||
| Pertussis (Whooping Cough) | 287 | ||
| Assessment Points | 287 | ||
| Pheochromocytoma | 289 | ||
| Assessment Points | 289 | ||
| Physiologic Anemia and the Anemia of Prematurity | 290 | ||
| Assessment Points (Apply to Preterm Infants Only) | 290 | ||
| Pickwickian Syndrome | 291 | ||
| Assessment Points | 291 | ||
| Pierre Robin Syndrome | 292 | ||
| Assessment Points | 292 | ||
| Pituitary Tumors | 293 | ||
| Assessment Points | 293 | ||
| Placenta Previa | 294 | ||
| Assessment Points | 294 | ||
| Pneumocystis Carinii Pneumonia (PCP) | 295 | ||
| Assessment Points | 295 | ||
| Post Transplant Lymphoproliferative Disease | 296 | ||
| Assessment Points | 296 | ||
| Postoperative Encephalopathy, Metabolic | 297 | ||
| Assessment Points | 297 | ||
| Prader-Willi Syndrome | 298 | ||
| Assessment Points | 298 | ||
| Preeclampsia | 299 | ||
| Assessment Points | 299 | ||
| Pregnancy, Ectopic | 300 | ||
| Assessment Points | 300 | ||
| Pregnancy, Intra-Abdominal | 302 | ||
| Assessment Points | 302 | ||
| Pregnancy, Maternal Physiology | 303 | ||
| Assessment Points | 303 | ||
| Pregnancy-Induced Hypertension | 305 | ||
| Assessment Points | 305 | ||
| Preterm Infant | 306 | ||
| Assessment Points | 306 | ||
| Protein C Deficiency | 308 | ||
| Assessment Points | 308 | ||
| Pulmonary Atresia | 309 | ||
| Assessment Points | 309 | ||
| Pulmonary Embolism | 310 | ||
| Assessment Points | 310 | ||
| Purpura, Immune Thrombocytopenic (ITP) | 311 | ||
| Assessment Points | 311 | ||
| Purpura, Thrombotic Thrombocytopenic (TTP) | 312 | ||
| Assessment Points | 312 | ||
| Pyloric Stenosis | 313 | ||
| Assessment Points | 313 | ||
| Q Fever | 314 | ||
| Assessment Points | 314 | ||
| Raynaud’s Phenomenon | 315 | ||
| Assessment Points | 315 | ||
| Reflex Sympathetic Dystrophy (Complex Peripheral Pain Syndrome) | 316 | ||
| Assessment Points | 316 | ||
| Renal Failure, Acute (ARF) | 317 | ||
| Assessment Points | 317 | ||
| Renal Failure, Chronic | 318 | ||
| Assessment Points | 318 | ||
| Respiratory Distress Syndrome | 319 | ||
| Assessment Points | 319 | ||
| Rett Syndrome | 320 | ||
| Assessment Points | 320 | ||
| Reye’s Syndrome | 321 | ||
| Assessment Points | 321 | ||
| Rheumatoid Arthritis | 322 | ||
| Assessment Points | 322 | ||
| Rocky Mountain Spotted Fever | 323 | ||
| Assessment Points | 323 | ||
| Sarcoidosis | 324 | ||
| Assessment Points | 324 | ||
| Sarcoma | 325 | ||
| Assessment Points | 325 | ||
| Schizophrenia | 326 | ||
| Assessment Points | 326 | ||
| Scleroderma | 327 | ||
| Assessment Points | 327 | ||
| Scoliosis and Kyphosis | 328 | ||
| Assessment Points | 328 | ||
| Seizures, Epileptic | 330 | ||
| Assessment Points | 330 | ||
| Seizures, Grand Mal (Tonic-Clonic) | 331 | ||
| Assessment Points | 331 | ||
| Seizures, Intractable | 332 | ||
| Assessment Points | 332 | ||
| Seizures, Petit Mal (Absence) | 333 | ||
| Assessment Points | 333 | ||
| Septic Shock, Hyperdynamic; Systemic Inflammatory Response Syndrome (SIRS) | 334 | ||
| Assessment Points | 334 | ||
| Shy-Drager Disease | 335 | ||
| Assessment Points | 335 | ||
| Sick Sinus Syndrome (SSS) | 336 | ||
| Assessment Points | 336 | ||
| Sickle Cell Disease | 337 | ||
| Assessment Points | 337 | ||
| Sickle Cell Trait | 338 | ||
| Assessment Points | 338 | ||
| Silicosis | 339 | ||
| Assessment points | 339 | ||
| Single (Including Common) Ventricle | 341 | ||
| Assessment Points | 341 | ||
| Sleep Apnea, Central and Mixed | 342 | ||
| Assessment Points | 342 | ||
| Sleep Apnea, Obstructive | 343 | ||
| Assessment Points | 343 | ||
| Spasmodic Torticollis | 344 | ||
| Assessment Points | 344 | ||
| Subclavian Steal Syndrome | 345 | ||
| Assessment Points | 345 | ||
| Subphrenic Abscess | 346 | ||
| Assessment Points | 346 | ||
| Supratentorial Brain Tumors | 347 | ||
| Assessment Points | 347 | ||
| Supraventricular Tachycardia (Tachyarrhythmias) | 349 | ||
| Assessment Points | 349 | ||
| Swallowing Disorders | 350 | ||
| Assessment Points | 350 | ||
| Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) | 351 | ||
| Assessment Points | 351 | ||
| Syndrome X | 352 | ||
| Assessment Points | 352 | ||
| Systemic Lupus Erythematosus | 353 | ||
| Assessment Points | 353 | ||
| Tetanus | 354 | ||
| Assessment Points | 354 | ||
| Tetralogy of Fallot (TOF) | 355 | ||
| Assessment Points | 355 | ||
| Thalassemia | 356 | ||
| Assessment Points | 356 | ||
| Thrombocytopenia | 358 | ||
| Assessment Points | 358 | ||
| Thyroid Neoplasms | 359 | ||
| Assessment Points | 359 | ||
| Transfusion-Related Acute Lung Injury (TRALI) | 360 | ||
| Assessment Points | 360 | ||
| Transverse Myelitis | 361 | ||
| Assessment Points | 361 | ||
| Treacher Collins Syndrome | 362 | ||
| Assessment Points | 362 | ||
| Tricuspid Atresia | 363 | ||
| Assessment Points | 363 | ||
| Trigeminal Neuralgia \n(TIC Doloureux) | 364 | ||
| Assessment Points | 364 | ||
| Truncus Arteriosus | 365 | ||
| Assessment Points | 365 | ||
| Tuberculosis (TB) | 367 | ||
| Assessment Points | 367 | ||
| Ulcerative Colitis, Chronic | 368 | ||
| Assessment Points | 368 | ||
| Upper Respiratory Infections | 369 | ||
| Assessment Points | 369 | ||
| Urinary Lithiasis | 370 | ||
| Assessment Points | 370 | ||
| Urticaria, Cold | 371 | ||
| Assessment Points | 371 | ||
| Uterine Rupture | 372 | ||
| Assessment Points | 372 | ||
| Varicella-Zoster Virus | 373 | ||
| Assessment Points | 373 | ||
| Ventricular Fibrillation | 374 | ||
| Assessment Points | 374 | ||
| Ventricular Preexcitation Syndrome | 375 | ||
| Assessment Points | 375 | ||
| Ventricular Septal Defect (Congenital) | 377 | ||
| Assessment Points | 377 | ||
| Ventricular Septal Rupture (Defect), Post Myocardial Infarction | 378 | ||
| Assessment Points | 378 | ||
| Ventricular Tachyarrhythmias | 379 | ||
| Assessment Points | 379 | ||
| Ventricular Tachycardia | 380 | ||
| Assessment Points | 380 | ||
| Vitamin B12/Folate Deficiency | 381 | ||
| Assessment Points | 381 | ||
| Vitamin D Deficiency | 382 | ||
| Assessment Points | 382 | ||
| Vitamin K Deficiency | 384 | ||
| Assessment Points | 384 | ||
| Von Willebrand’s Disease | 385 | ||
| Assessment Points | 385 | ||
| Waldenström’s Macroglobulinemia | 386 | ||
| Assessment Points | 386 | ||
| Wilms’ Tumor | 387 | ||
| Assessment Points | 387 | ||
| Wolff-Parkinson-White (WPW) Syndrome | 388 | ||
| Assessment Points | 388 | ||
| Section II: Procedures | 389 | ||
| Abdominal Aortic Aneurysm Repair | 390 | ||
| Assessment Points | 390 | ||
| Abdominoperineal Resection | 391 | ||
| Assessment Points | 391 | ||
| Adrenalectomy for Pheochromocytoma | 392 | ||
| Assessment Points | 392 | ||
| Laparoscopic Adrenalectomy | 393 | ||
| Assessment Points | 393 | ||
| Advanced Cardiac Life Support (ACLS) | 395 | ||
| Assessment Points | 395 | ||
| Amputation, Above-Knee (AKA) | 396 | ||
| Assessment Points | 396 | ||
| Amputation, Lower Extremity (LEA) | 397 | ||
| Assessment Points | 397 | ||
| Aneurysm Coiling | 398 | ||
| Assessment Points | 398 | ||
| Anterior Cervical Discectomy and Fusion (ACDF) | 400 | ||
| Assessment Points | 400 | ||
| Aortic Valve Replacement | 401 | ||
| Assessment Points | 401 | ||
| Aortopulmonary Window | 402 | ||
| Assessment Points | 402 | ||
| Appendectomy | 403 | ||
| Assessment Points | 403 | ||
| Atrial Fibrillation Ablation | 404 | ||
| Assessment Points | 404 | ||
| Atrial Septal Defect, Repair of | 406 | ||
| Assessment Points | 406 | ||
| AV Graft for Hemodialysis | 407 | ||
| Assessment Points | 407 | ||
| Blalock-Taussig Shunt (BTS) | 409 | ||
| Assessment Points | 409 | ||
| Blood Components | 410 | ||
| Assessment Points | 410 | ||
| Blowout Orbital Fracture | 411 | ||
| Assessment Points | 411 | ||
| Bone Marrow Transplantation (Harvest Procedure) | 412 | ||
| Assessment Points | 412 | ||
| Bowel Resection | 413 | ||
| Assessment Points | 413 | ||
| Brain Cortex Resection \n(for Epilepsy) | 414 | ||
| Assessment Points | 414 | ||
| Breast Biopsy | 416 | ||
| Assessment Points | 416 | ||
| Bronchoscopy, Fiberoptic | 417 | ||
| Assessment Points | 417 | ||
| Bronchoscopy, Rigid | 418 | ||
| Assessment Points | 418 | ||
| Burr Hole | 419 | ||
| Assessment Points | 419 | ||
| Bypass, Femoral-Femoral | 420 | ||
| Assessment Points | 420 | ||
| Bypass Graft Procedure, Infrainguinal | 421 | ||
| Assessment Points | 421 | ||
| Carcinoid, Excision of | 423 | ||
| Assessment Points | 423 | ||
| Cardiopulmonary Bypass (CPB) | 425 | ||
| Assessment Points | 425 | ||
| Cardioversion | 426 | ||
| Assessment Points | 426 | ||
| Carotid Endarterectomy | 427 | ||
| Assessment Points | 427 | ||
| Carpal Tunnel Syndrome | 428 | ||
| Assessment Points | 428 | ||
| Cataract ± Iol | 429 | ||
| Assessment Points | 429 | ||
| Cerebral AVM Repair | 430 | ||
| Assessment Points | 430 | ||
| Cervical Spine Fusion | 431 | ||
| Assessment Points | 431 | ||
| Cesarean Section, Emergent | 432 | ||
| Assessment Points | 432 | ||
| Cesarean Section, Planned | 434 | ||
| Assessment Points | 434 | ||
| Cholecystectomy, Laparoscopic | 435 | ||
| Assessment Points | 435 | ||
| Cholecystectomy, Open | 436 | ||
| Assessment Points | 436 | ||
| Circumcision | 437 | ||
| Assessment Points | 437 | ||
| Cleft Lip Repair | 438 | ||
| Assessment Points | 438 | ||
| Cleft Palate Repair | 439 | ||
| Assessment Points | 439 | ||
| Colostomy | 440 | ||
| Assessment Points | 440 | ||
| Coronary Artery Bypass \nGraft (CABG) | 441 | ||
| Assessment Points | 441 | ||
| Craniotomy | 442 | ||
| Assessment Points | 442 | ||
| Craniotomy, Awake | 443 | ||
| Assessment Points | 443 | ||
| Craniotomy, Sitting Position | 444 | ||
| Assessment Points | 444 | ||
| Electroconvulsive Therapy (ECT) | 445 | ||
| Assessment Points | 445 | ||
| Endoscopic Sinus Surgery (ESS) | 447 | ||
| Assessment Points | 447 | ||
| Endovascular Aortic Stent Repairs | 448 | ||
| Assessment Points | 448 | ||
| Esophagectomy | 449 | ||
| Assessment Points | 449 | ||
| Extracorporeal Membrane Oxygenation (ECMO) | 450 | ||
| Assessment Points | 450 | ||
| Extracorporeal Shock Wave Lithotripsy (ESWL) | 451 | ||
| Assessment Points | 451 | ||
| Eye Enucleation | 452 | ||
| Assessment Points | 452 | ||
| Gas Embolism | 453 | ||
| Assessment Points | 453 | ||
| Gastrectomy | 454 | ||
| Assessment Points | 454 | ||
| Gastric Bypass Stapling for Morbid Obesity | 455 | ||
| Assessment Points | 455 | ||
| Gastroschisis Surgery | 456 | ||
| Assessment Points | 456 | ||
| Geriatric Surgery | 457 | ||
| GI Endoscopy/EGD, Non-Operating Room Anesthesia | 458 | ||
| Assessment Points | 458 | ||
| GIFT Procedure | 459 | ||
| Assessment Points | 459 | ||
| Heart Transplant, Adult | 460 | ||
| Assessment Points | 460 | ||
| Heart Transplant, Pediatric | 461 | ||
| Assessment Points | 461 | ||
| Herniorrhaphy | 462 | ||
| Assessment Points | 462 | ||
| Hip Fracture Repair | 463 | ||
| Assessment Points | 463 | ||
| Hypospadias Repair | 464 | ||
| Assessment Points | 464 | ||
| Hysterectomy, Vaginal | 465 | ||
| Assessment Points | 465 | ||
| Hysteroscopy | 466 | ||
| Assessment Points | 466 | ||
| Ileostomy | 467 | ||
| Assessment Points | 467 | ||
| Imperforate Anus Repair | 468 | ||
| Assessment Points | 468 | ||
| Implantable Cardioverter\nDefibrillators (ICDs), Implantation | 470 | ||
| Assessment Points | 470 | ||
| Inguinal Herniorrhaphy | 472 | ||
| Assessment Points | 472 | ||
| Intestinal Obstruction | 473 | ||
| Assessment Points | 473 | ||
| Intra-Aortic Balloon Counterpulsation (IABCP) | 474 | ||
| Assessment Points | 474 | ||
| Intussuscepted Bowel Repair | 475 | ||
| Assessment Points | 475 | ||
| Joint Replacement Cementing (Methylmethacrylate Cementing) | 476 | ||
| Assessment Points | 476 | ||
| Kasai Procedure | 477 | ||
| Assessment Points | 477 | ||
| Kidney Transplantation | 478 | ||
| Assessment Points | 478 | ||
| Knee Arthroscopy | 479 | ||
| Assessment Points | 479 | ||
| Labor, Epidural Block | 480 | ||
| Assessment Points | 480 | ||
| Labor, Peripheral Blocks | 482 | ||
| Assessment Points | 482 | ||
| Laparoscopy, Gynecologic | 483 | ||
| Assessment Points | 483 | ||
| Laryngoscopy | 484 | ||
| Assessment Points | 484 | ||
| Laser Surgery of Airway | 485 | ||
| Assessment Points | 485 | ||
| Liver Resection | 486 | ||
| Assessment Points | 486 | ||
| Liver Transplantation | 487 | ||
| Assessment Points | 487 | ||
| Liver Transplantation, Pediatric | 489 | ||
| Assessment Points | 489 | ||
| Lumbar Laminectomy | 491 | ||
| Assessment Points | 491 | ||
| Lung Transplantation | 493 | ||
| Assessment Points | 493 | ||
| Lung Volume Reduction Surgery (LVRS) | 495 | ||
| Assessment Points | 495 | ||
| Mastectomy | 496 | ||
| Assessment Points | 496 | ||
| Meningomyelocele Repair | 497 | ||
| Assessment Points | 497 | ||
| Mitral Valve Replacement | 498 | ||
| Assessment Points | 498 | ||
| Muscle Biopsy for Undiagnosed Myopathy | 500 | ||
| Assessment Points | 500 | ||
| Myringotomy and Tympanostomy | 501 | ||
| Assessment Points | 501 | ||
| Nephrectomy/Radical Nephrectomy | 502 | ||
| Assessment Points | 502 | ||
| Neuroprotection | 503 | ||
| Assessment Points | 503 | ||
| Neuroradiology | 504 | ||
| Assessment Points | 504 | ||
| Off Pump and Minimally Invasive Cardiac Procedures | 505 | ||
| Assessment Points | 505 | ||
| Office-Based Anesthesia | 506 | ||
| Assessment Points | 506 | ||
| Omphalocele Surgery | 507 | ||
| Assessment Points | 507 | ||
| Orchiopexy | 508 | ||
| Assessment Points | 508 | ||
| ORIF of Hip | 509 | ||
| Assessment Points | 509 | ||
| Pacemaker Implantation for Sick Sinus Syndrome | 510 | ||
| Assessment Points | 510 | ||
| Pancreas Transplantation | 511 | ||
| Assessment Points | 511 | ||
| Parathyroidectomy | 512 | ||
| Assessment Points | 512 | ||
| Patent Ductus Arteriosus (PDA), Ligation of | 513 | ||
| Assessment Points | 513 | ||
| Pituitary Resection, Transsphenoidal Approach | 514 | ||
| Assessment Points | 514 | ||
| Pneumonectomy | 516 | ||
| Assessment Points | 516 | ||
| Pregnant Surgical Patient | 517 | ||
| Assessment Points | 517 | ||
| Pyloric Stenosis Repair | 518 | ||
| Assessment Points | 518 | ||
| Radical Neck Dissection | 519 | ||
| Assessment Points | 519 | ||
| Radical Prostatectomy (Retropubic) | 520 | ||
| Assessment Points | 520 | ||
| Retained Placenta, Removal of | 521 | ||
| Assessment Points | 521 | ||
| Retinal Buckle Surgery | 522 | ||
| Assessment Points | 522 | ||
| Retropharyngeal and Peritonsillar Abscess Drainage in Adults | 523 | ||
| Assessment Points | 523 | ||
| Rotator Cuff Repair | 524 | ||
| Assessment Points | 524 | ||
| Scoliosis and Kyphosis Surgery | 525 | ||
| Assessment Points | 525 | ||
| Seizure Surgery | 527 | ||
| Assessment Points | 527 | ||
| Spinal Fusion | 529 | ||
| Assessment Points | 529 | ||
| Splenectomy | 531 | ||
| Assessment Points | 531 | ||
| Split-Thickness Skin Graft | 532 | ||
| Assessment Points | 532 | ||
| Stereotactic Neurosurgery | 533 | ||
| Assessment Points | 533 | ||
| Strabismus Repair | 535 | ||
| Assessment Points | 535 | ||
| Testicular Torsion Surgery | 536 | ||
| Assessment Points | 536 | ||
| Tetralogy of Fallot, Correction of | 537 | ||
| Assessment Points | 537 | ||
| Thoracic Aortic Repair | 538 | ||
| Assessment Points | 538 | ||
| Thyroidectomy (Open or Minimally Invasive) for Hyperthyroidism | 540 | ||
| Assessment Points | 540 | ||
| TMJ Arthroscopy | 541 | ||
| Assessment Points | 541 | ||
| Tonsillectomy and Adenoidectomy | 542 | ||
| Assessment Points | 542 | ||
| Total Abdominal Hysterectomy | 543 | ||
| Assessment Points | 543 | ||
| Total Anomalous Pulmonary Venous Return Correction | 544 | ||
| Assessment Points | 544 | ||
| Total Hip Arthroplasty | 545 | ||
| Assessment Points | 545 | ||
| Total Knee Arthroplasty | 546 | ||
| Assessment Points | 546 | ||
| Tracheal Resection | 547 | ||
| Assessment Points | 547 | ||
| Tracheoesophageal Fistula Repair | 548 | ||
| Assessment Points | 548 | ||
| Tracheotomy/Tracheostomy and Cricothyroidotomy | 549 | ||
| Assessment Points | 549 | ||
| Transjugular Intrahepatic Portosystemic Shunt (TIPS) | 550 | ||
| Assessment Points | 550 | ||
| Transposition of the Great Arteries (TGA) | 552 | ||
| Assessment Points | 552 | ||
| Transposition of€the Great Arteries, \nL Form (L-TGA) | 553 | ||
| Assessment Points | 553 | ||
| Transsphenoidal Surgery | 554 | ||
| Assessment Points | 554 | ||
| Transurethral Resection of Bladder Tumor | 555 | ||
| Assessment Points | 555 | ||
| Transurethral Resection of Prostate (TURP) | 556 | ||
| Assessment Points | 556 | ||
| Trauma | 557 | ||
| Assessment Points | 557 | ||
| Tubal Ligation | 558 | ||
| Assessment Points | 558 | ||
| Ureteral Reimplantation | 560 | ||
| Assessment Points | 560 | ||
| Ureteral Stent Placement | 561 | ||
| Assessment Points | 561 | ||
| Vaginal Delivery, Normal | 562 | ||
| Assessment Points | 562 | ||
| Venous Air Embolism | 563 | ||
| Assessment Points | 563 | ||
| Ventricular Septal Defect, Repair of | 564 | ||
| Assessment Points | 564 | ||
| Ventriculoperitoneal Shunt | 566 | ||
| Assessment Points | 566 | ||
| Whipple Procedure (Pancreatico Duodenectomy) | 567 | ||
| Assessment Points | 567 | ||
| Section III: Drugs | 569 | ||
| ACE Inhibitors | 570 | ||
| Assessment Points | 570 | ||
| Acetaminophen | 571 | ||
| Assessment Points | 571 | ||
| Alkylating Agents | 572 | ||
| Drug Effects | 572 | ||
| Alpha-2 Adrenergic Agonists | 573 | ||
| Drug Effects | 573 | ||
| Aminophylline | 575 | ||
| Drug Effects | 575 | ||
| Amphetamines | 576 | ||
| Drug Effects | 576 | ||
| Angiotensin II Receptor \nBlocking Drugs | 577 | ||
| Drug Effects | 577 | ||
| Aspirin (Acetylsalicylic Acid) | 578 | ||
| Drug Effects | 578 | ||
| Asthma Drugs, New | 579 | ||
| Atorvastatin (Lipitor) | 580 | ||
| Drug Effects | 580 | ||
| Atropine | 581 | ||
| Assessment Points | 581 | ||
| Benzodiazepines (Midazolam, Lorazepam, Diazepam) | 582 | ||
| Drug Effects | 582 | ||
| Beta-Adrenergic Receptor Antagonists (Blockers) | 583 | ||
| Drug Effects | 583 | ||
| Bicarbonate Sodium | 584 | ||
| Drug Effects | 584 | ||
| Bleomycin | 585 | ||
| Assessment Points | 585 | ||
| Calcium-Channel Blockers | 586 | ||
| Assessment Points | 586 | ||
| Capsaicin | 587 | ||
| Drug Effects | 587 | ||
| Carbamazepine | 588 | ||
| Drug Effects | 589 | ||
| Chemotherapeutic Agents | 590 | ||
| Drug Class | 590 | ||
| Chloramphenicol (Chloromycetin) | 592 | ||
| Drug Effects | 592 | ||
| Cimetidine | 593 | ||
| Drug Effects | 593 | ||
| Cisplatin | 594 | ||
| Drug Effects | 594 | ||
| Clopidogrel Bisulfate | 595 | ||
| Drug Effects | 595 | ||
| Cocaine | 596 | ||
| Drug Effects | 596 | ||
| Cromolyn Sodium | 597 | ||
| Drug Effects | 597 | ||
| Dexmedetomidine (Precedex) | 598 | ||
| Drug Effects | 598 | ||
| Digitalis (Digoxin) | 599 | ||
| Drug Effects | 599 | ||
| Diuretics | 600 | ||
| Drug Effects | 600 | ||
| Dobutamine | 601 | ||
| Drug Effects | 601 | ||
| Dopamine | 602 | ||
| Drug Effects | 602 | ||
| Doxorubicin (Adriamycin) Daunorubicin (Cerubidine) | 603 | ||
| Drug Effects | 603 | ||
| Ephedrine | 604 | ||
| Drug Effects | 604 | ||
| Epinephrine | 605 | ||
| Drug Effects | 605 | ||
| Epsilon-Aminocaproic Acid (EACA) (Amicar) | 606 | ||
| Drug Effects | 606 | ||
| Fluoxetine (Prozac) | 607 | ||
| Drug Effects | 607 | ||
| Folic Acid | 608 | ||
| Drug Effects | 608 | ||
| Gold (Auranofin, Aurothioglucose, Aurothiomalate) | 609 | ||
| Drug Effects | 609 | ||
| Haloperidol (Haldol) | 610 | ||
| Drug Effects | 610 | ||
| Hormone Replacement \nTherapy (HRT) | 611 | ||
| Drug Effects | 611 | ||
| Insulin Receptor Modifiers | 612 | ||
| Drug Effects | 612 | ||
| Isoproterenol (Isuprel,€Medihaler-ISO) | 613 | ||
| Drug Effects | 613 | ||
| Lithium Carbonate (Lithobid) | 614 | ||
| Drug Effects | 614 | ||
| Magnesium Sulfate | 615 | ||
| Drug Effects | 615 | ||
| Marijuana | 616 | ||
| Drug Effects | 616 | ||
| Metformin (Glucophage) | 618 | ||
| Assessment Points | 618 | ||
| Monoamine Oxidase Inhibitors; Reversible Inhibitors of Monoamine Oxidase | 619 | ||
| Drug Effects | 619 | ||
| Nicotine Replacment Therapies (NRTs) | 620 | ||
| Drug Effects | 620 | ||
| Nitric Oxide (NO), Inhaled | 621 | ||
| Drug Effects | 621 | ||
| Nitroglycerin | 622 | ||
| Assessment Points | 622 | ||
| Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) | 623 | ||
| Assessment Points | 623 | ||
| Nutritional Support | 624 | ||
| Assessment Points | 624 | ||
| Oral Contraceptives | 625 | ||
| Drug Effects | 625 | ||
| Oral Hypoglycemics | 626 | ||
| Assessment Points | 626 | ||
| Penicillins | 627 | ||
| Drug Effects | 627 | ||
| Phencyclidine (PCP) | 628 | ||
| Assessment Points | 628 | ||
| Phenothiazines | 629 | ||
| Assessment Points | 629 | ||
| Phenoxybenzamine | 630 | ||
| Drug Effects | 630 | ||
| Phenylephrine (Neo-Synephrine) | 631 | ||
| Assessment Points | 631 | ||
| Phenytoin | 632 | ||
| Drug Effects | 632 | ||
| Physostigmine, Eserine | 633 | ||
| Drug Effects | 633 | ||
| Prilocaine (Citanest) | 634 | ||
| Drug Effects | 634 | ||
| Assessment Points | 634 | ||
| Procainamide (Procan, Procanabid, Pronestyl) | 635 | ||
| Drug Effects | 635 | ||
| Propylthiouracil—Antithyroid Drugs | 636 | ||
| Drug Effects | 636 | ||
| Pyridostigmine Bromide | 637 | ||
| Drug Effects | 637 | ||
| Quinidine | 638 | ||
| Drug Effects | 638 | ||
| Riboflavin (Vitamin B2) | 639 | ||
| Assessment Points | 639 | ||
| Rifampin | 640 | ||
| Assessment Points | 640 | ||
| Serotonin: Agonists, Antagonists, and Reuptake Inhibitors | 641 | ||
| Assessment Points | 641 | ||
| Sildenafil Citrate | 642 | ||
| Assessment Points | 642 | ||
| Statins | 643 | ||
| Side Effects | 643 | ||
| Steroids | 644 | ||
| Drug Effects | 644 | ||
| Tacrolimus (FK-506) | 646 | ||
| Drug Effects | 646 | ||
| Terbutaline | 647 | ||
| Drug Effects | 647 | ||
| Tetracyclines | 648 | ||
| Assessment Points | 648 | ||
| Thyroid Supplements | 649 | ||
| Assessment Points | 649 | ||
| Tissue Plasminogen Activator | 650 | ||
| Assessment Points | 650 | ||
| Tranexamic Acid | 651 | ||
| Assessment Points | 651 | ||
| Trimethaphan | 652 | ||
| Assessment Points | 652 | ||
| Vitamin B 12\n (Cyanocobalamin) | 653 | ||
| Assessment Points | 653 | ||
| Warfarin (Coumadin) | 654 | ||
| Assessment Points | 654 | ||
| Androstenedione | 656 | ||
| Drug Effects | 656 | ||
| β-Sitosterol | 657 | ||
| Assessment Points | 657 | ||
| Blue Cohosh (Caulophyllum Thalictroides) | 658 | ||
| Assessment Points | 658 | ||
| Carnitine | 659 | ||
| Assessment Points | 659 | ||
| Chitosan | 660 | ||
| Drug Effects | 660 | ||
| Red Yeast Rice (Cholestin) | 661 | ||
| Assessment Points | 661 | ||
| Chondroitin Sulfate | 662 | ||
| Assessment Points | 662 | ||
| Chromium | 663 | ||
| Assessment Points | 663 | ||
| Cranberry | 664 | ||
| Assessment Points | 664 | ||
| Creatine | 665 | ||
| Assessment Points | 665 | ||
| Dandelion | 666 | ||
| Assessment Points | 666 | ||
| Dehydroepiandrosterone (DHEA) | 667 | ||
| Drug Effects | 667 | ||
| Echinacea (American Coneflower, Purple Coneflower: E. Angustifolia, E. Purpurea, E. Pallida) | 668 | ||
| Drug Effects | 668 | ||
| Ephedra (Ma-Huang) | 669 | ||
| Assessment Points | 669 | ||
| Evening Primrose | 670 | ||
| Drug Effects | 670 | ||
| Fish Oil | 671 | ||
| Assessment Points | 671 | ||
| Garlic (Allium sativum) | 672 | ||
| Assessment Points | 672 | ||
| Ginger (Zingiber officinale) | 673 | ||
| Assessment Points | 673 | ||
| Ginkgo | 674 | ||
| Assessment Points | 674 | ||
| Ginseng | 675 | ||
| Drug Effects | 675 | ||
| Glucosamine Sulfate | 676 | ||
| Drug Effects | 676 | ||
| Glycine | 677 | ||
| Assessment Points | 677 | ||
| Goldenseal (Hydrastis Canadensis) | 678 | ||
| Assessment Points | 678 | ||
| Licorice (Glycyrrhiza Glabra) | 679 | ||
| Assessment Points | 679 | ||
| Melatonin ( N -Acetyl-5-Methoxytryptamine, Bevitamel, Vitamist, Melatonex) | 680 | ||
| Assessment Points | 680 | ||
| Nutraceuticals | 681 | ||
| Drug Effects | 681 | ||
| Phytosterols | 682 | ||
| Assessment Points | 682 | ||
| Pseudoephedrine | 683 | ||
| Drug Effects | 683 | ||
| Psyllium, Bulk-Forming Laxatives (Plantago Isphagula, Plantago Ovata) | 684 | ||
| Drug Effects | 684 | ||
| Pyruvate | 685 | ||
| Drug Effects | 685 | ||
| S-Adenosyl-L\n-Methionine (SAMe) | 686 | ||
| Assessment Points | 686 | ||
| Saw Palmetto | 687 | ||
| Drug Effects | 687 | ||
| Soy | 688 | ||
| Drug Effects | 688 | ||
| St. John’s Wort (Hypericum Perforatum) | 689 | ||
| Assessment Points | 689 | ||
| Valerian (Valeriana officinalis) | 690 | ||
| Drug Effects | 690 | ||
| Autonomic Function | 692 | ||
| Assessment Points | 692 | ||
| Chest X-Ray | 693 | ||
| Assessment Points | 693 | ||
| Diagnostic 12-Lead ECG | 694 | ||
| Assessment Points | 694 | ||
| Dibucaine Number (Atypical Cholinesterase) | 695 | ||
| Assessment Points | 695 | ||
| Dipyridamole Thallium Imaging | 696 | ||
| Assessment Points | 696 | ||
| Dobutamine Echocardiography | 697 | ||
| Assessment Points | 697 | ||
| Exercise Stress Testing | 698 | ||
| Flow-Volume Loops | 699 | ||
| Assessment Points | 699 | ||
| HIV Testing | 700 | ||
| Liver Function Tests (LFTs) | 701 | ||
| Assessment Points | 701 | ||
| Pregnancy Testing | 702 | ||
| Assessment Points | 702 | ||
| Renal Function Testing | 703 | ||
| Assessment Points | 703 | ||
| Spirometry | 704 | ||
| Assessment Points | 704 | ||
| Transesophageal Echocardiography (TEE) | 705 | ||
| V/Q Scan (Nuclear Ventilation-Perfusion Scintigraphy) | 706 | ||
| Assessment Points | 706 | ||
| Index | 707 |